Accounting Customer service Hiring & human resources Legal Management Raising money Sales & marketing Selling a business Startup Technology Small & Global How We Got Started Biz Books Innovators Owner Tested Tech Edge Best Bosses Next Little Thing Startup Showdown Current Issue Archive

Biotech for bees

One Miami startup hopes to cure a mysterious plague threatening the food supply.

EMAIL  |   PRINT  |   SHARE  |   RSS
 
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)

bee_pollen.ce.03.jpg
Photos
Next Little Thing 2009 Next Little Thing 2009 Next Little Thing 2009
Each year Fortune Small Business celebrates entrepreneurs whose cutting-edge ideas will keep us talking for the next 12 months. Check out this year's crop of flying cars, blimp power and GPS-enhanced cows.

(Fortune Small Business) -- Bee colonies might not seem like the most lucrative market for designer drugs. But the need is urgent: CCD, or colony collapse disorder, a strange syndrome that kills adult worker bees outside the hive, has been reported across the U.S. and Europe. The U.S. Department of Agriculture (USDA) says American beekeepers lost 37% of their hives to CCD last year, after losing 31% the year before.

Scientists still can't agree on which virus, if any, causes CCD. The government estimates that a third of our food supply - $15 billion annually in vegetables, nuts and fruits from plants that depend on bees for pollination - could be in danger.

Enter Beeologics, a Miami biotech startup that aims to create vaccines for all viruses that could lead to CCD. It's an unlikely collaboration between Eyal Ben-Chanoch, 49, a tech entrepreneur who helped design the first Intel (INTC, Fortune 500) Pentium chip, and Ilan Sela, 71, an Israeli expert on sequencing the genomes of bee viruses.

The pair saw a crisis no other company was responding to and gathered 10 top researchers to work on a cure.

"There hasn't been a lot of support for bee health," says Ben-Chanoch. "Our mission is to fill that void." The company's first proprietary vaccine, Remebee, is in trials with six beekeepers. (Poking insects with syringes is tricky, so the drug is added to a sucrose solution used to feed bees.)

FDA approval is still pending, but the company is confident it will be able to commercialize the vaccine this summer, at around $2 per dose. A hive will need one dose per month. Multiply that by the nation's 2.5 million remaining hives, and Beeologics could soon be buzzing with revenues.

Jeff Pettis, head of the USDA's Bee Research Laboratory, is cautiously enthusiastic about Remebee's potential. CCD likely stems from multiple factors, he says, some of which have yet to be discovered. But with time running out before the food chain is affected, any cure is worth trying.

"We live in a land of milk and honey," says Pettis, "but the honey can no longer be taken for granted."  To top of page

To write a note to the editor about this article, click here.

  • pile_money.ju.04.jpg
    Small business grants are rare, but they do exist. Here's how to find them. More
  • ann_marie.04.jpg
    These 7 entrepreneurs are bringing tech, medical research and design jobs to the Detroit metro area. More
  • credit_cards.04.jpg
    As traditional loans dry up, banks are funneling more of their small business lending through credit cards. More
  • frattini_dfd_26.04.jpg
    Arson. Scrappers. Blackouts. It's part of business for the last tenant in Detroit's Packard Plant. More
  • scott_pinizzotto.04.jpg
    Inventing is the easy part. Marketing? Trickier. Experts tell how they'd advertise 5 hard-to-tout products. More
  • dead_zone.04.jpg
    Every restaurateur knows about Cursed Locations, the addresses where no venture survives. More
  • charles_ellis.04.jpg
    Detroit's churches are plowing millions into redeveloping local housing and businesses. More



QWe've run a dinner theater for three decades. We've been operating at a loss for the last couple of years, and are unable to get a loan. We even closed for two months this summer to save money. We don't know what to do. More
Get Answer
- Kyle, Sarasota, Fla.

Sponsors
More Galleries
Would you walk away? With 1 in 4 homeowners underwater, many pundits predict a flood of people walking away from their homes. 5 readers discuss why they are - and are not - sticking around. More
Are things really getting better? Last quarter, the economy grew by the largest amount since the summer of 2007, but there are signs that things are still getting worse. More
7 wicked Black Friday Car deals It turns out the day after Thanksgiving is a great day to shop for a car. Here a few deals that deserve special attention. More

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.